BioLife Solutions (BLFS) Misses Q4 EPS by 20c
Tweet
Share
E-mailGet Alerts BLFS Hot Sheet
Price: $35.23 +0.74%
Financial Fact:
Cost of product sales: 920.94K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Cost of product sales: 920.94K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
BioLife Solutions (NASDAQ: BLFS) reported Q4 EPS of ($0.37), $0.20 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $37.3 million versus the consensus estimate of $35.81 million.
GUIDANCE:
BioLife Solutions sees FY2022 revenue of $159.5-171 million.
For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- KinderCare Learning Companies, Inc. (KLC) Misses Q2 EPS by 2c; Offers Guidance
- Assembly Biosciences (ASMB) Tops Q2 EPS by 53c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
